Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients (Q90289055)

From Wikidata

Jump to navigation Jump to search

scientific article published on 05 December 2018

Language	Label	Description	Also known as
English	Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients	scientific article published on 05 December 2018

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Wei Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Xiao-Dong Mo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Xiao-Hui Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Lan-Ping Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Yu Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Chen-Hua Yan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Huan Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Yu-Hong Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Wei Han

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Feng-Rong Wang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Jing-Zhi Wang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Kai-Yan Liu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

publication date

5 December 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

1198-1207

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study.

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant.

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

A single course of all-trans retinoic acid plus arsenic trioxide reached a long-term survival in a patient with newly diagnosed acute promyelocytic leukemia: a suggestion for reduction of treatment courses?

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage chemotherapy followed by granulocyte colony-stimulating factor-primed donor leukocyte infusion with graft-vs.-host disease control for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem ce

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-α in acute myeloid leukemia: an old drug revisited

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

IFN-α Is Effective for Treatment of Minimal Residual Disease in Patients with Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Registry Study

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantatio

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplanta

1 reference

https://api.crossref.org/works/10.1038/S41409-018-0406-Z

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/S41409-018-0406-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30518981 AND SRC:MED&resulttype=core&format=json

12 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q90289055&oldid=1531667957"